-
公开(公告)号:US06855716B2
公开(公告)日:2005-02-15
申请号:US10025589
申请日:2001-12-26
申请人: Seiji Ohno , Akiko Okajima , Seiji Niwa , Morikazu Kito , Akira Takahara , Yukitsugu Ono , Yuki Kajigaya , Tomoko Takeda , Hajime Koganei
发明人: Seiji Ohno , Akiko Okajima , Seiji Niwa , Morikazu Kito , Akira Takahara , Yukitsugu Ono , Yuki Kajigaya , Tomoko Takeda , Hajime Koganei
IPC分类号: A61P25/00 , A61P25/28 , C07D239/20 , C07D239/22 , C07D401/04 , C07D401/12 , C07D521/00 , A61K31/505 , A61K31/506 , C07D403/04
CPC分类号: C07D239/22 , C07D231/12 , C07D233/56 , C07D239/20 , C07D249/08 , C07D401/04 , C07D401/12
摘要: Dihydropyrimidine derivatives of the following formula or analogs thereof have selective N-type calcium channel antagonistic activity, and they are used as therapeutic agents for various diseases participating in the N-type calcium channels.
摘要翻译: 下式的二氢嘧啶衍生物或其类似物具有选择性的N型钙通道拮抗活性,并且它们用作参与N型钙通道的各种疾病的治疗剂。
-
公开(公告)号:US07247645B2
公开(公告)日:2007-07-24
申请号:US10022874
申请日:2001-12-20
申请人: Chika Nakanishi , Yoko Masuzawa , Masako Hagihara , Takashi Yamamoto , Hiroyuki Matsueda , Seiji Ohno , Seiji Niwa , Morikazu Kito , Akira Takahara , Yukitsugu Ono , Tomoko Takeda , Yuki Kajigaya , Hajime Koganei
发明人: Chika Nakanishi , Yoko Masuzawa , Masako Hagihara , Takashi Yamamoto , Hiroyuki Matsueda , Seiji Ohno , Seiji Niwa , Morikazu Kito , Akira Takahara , Yukitsugu Ono , Tomoko Takeda , Yuki Kajigaya , Hajime Koganei
IPC分类号: A61K31/4436 , A61K31/4439 , A61K31/4545 , C07D401/04 , C07D407/06
CPC分类号: C07D211/90
摘要: Compounds having a selective N-type calcium channel antagonistic activity are provided. Dihydropyridine derivatives represented by the following formula: analogs thereof and pharmaceutically acceptable salts thereof have an activity of selectively inhibiting the action of N-type calcium channel, and they are used as therapeutic agents for various diseases relating to N-type calcium channel.
摘要翻译: 提供具有选择性N型钙通道拮抗活性的化合物。 由下式表示的二氢吡啶衍生物:其类似物和其药学上可接受的盐具有选择性抑制N-型钙通道作用的活性,并且它们用作各种与N-型钙通道有关的疾病的治疗剂。
-
公开(公告)号:US20080070903A1
公开(公告)日:2008-03-20
申请号:US11856339
申请日:2007-09-17
申请人: Seiji OHNO , Kayo Otani , Seiji Niwa , Satoshi Iwayama , Akira Takahara , Hajime Koganei , Yukitsugu Ono , Shinichi Fujita , Tomoko Takeda , Masako Hagihara , Akiko Okajima
发明人: Seiji OHNO , Kayo Otani , Seiji Niwa , Satoshi Iwayama , Akira Takahara , Hajime Koganei , Yukitsugu Ono , Shinichi Fujita , Tomoko Takeda , Masako Hagihara , Akiko Okajima
IPC分类号: A61K31/55 , A61K31/44 , A61K31/445 , A61K31/496 , A61P9/00 , C07D221/00 , C07D239/24 , C07D295/00 , C07D223/02 , C07D213/02 , A61P25/00 , A61K31/505 , A61K31/506
CPC分类号: C07D213/80 , A61K31/455 , A61K31/496 , A61K31/505 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K31/551 , C07D213/82 , C07D239/28 , C07D239/34 , C07D239/38 , C07D239/42 , C07D401/04 , C07D403/04 , C07D409/04 , C07D417/04
摘要: Achiral pyrimidine derivatives and pyridine derivatives of the following formulae or analogs thereof have selective N-type calcium channel antagonistic activity and showed analgesic action when they were taken orally. They are useful as therapeutic agents for pains and various diseases associated with the N-type calcium channels.
摘要翻译: 下列通式或其类似物的手性嘧啶衍生物和吡啶衍生物具有选择性的N型钙通道拮抗活性,口服时显示镇痛作用。 它们可用作与N型钙通道相关的疼痛和各种疾病的治疗剂。
-
4.
公开(公告)号:US07288544B2
公开(公告)日:2007-10-30
申请号:US10387543
申请日:2003-03-14
申请人: Seiji Ohno , Kayo Otani , Seiji Niwa , Satoshi Iwayama , Akira Takahara , Hajime Koganei , Yukitsugu Ono , Shinichi Fujita , Tomoko Takeda , Masako Hagihara , Akiko Okajima
发明人: Seiji Ohno , Kayo Otani , Seiji Niwa , Satoshi Iwayama , Akira Takahara , Hajime Koganei , Yukitsugu Ono , Shinichi Fujita , Tomoko Takeda , Masako Hagihara , Akiko Okajima
IPC分类号: C07D239/338 , C07D403/04 , A61K31/505
CPC分类号: C07D213/80 , A61K31/455 , A61K31/496 , A61K31/505 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K31/551 , C07D213/82 , C07D239/28 , C07D239/34 , C07D239/38 , C07D239/42 , C07D401/04 , C07D403/04 , C07D409/04 , C07D417/04
摘要: Achiral pyrimidine derivatives and pyridine derivatives of the following formulae or analogs thereof have selective N-type calcium channel antagonistic activity and showed analgesic action when they were taken orally. They are useful as therapeutic agents for pains and various diseases associated with the N-type calcium channels
摘要翻译: 下列通式或其类似物的手性嘧啶衍生物和吡啶衍生物具有选择性的N型钙通道拮抗活性,口服时显示镇痛作用。 它们可用作与N型钙通道相关的疼痛和各种疾病的治疗剂
-
公开(公告)号:US07494989B2
公开(公告)日:2009-02-24
申请号:US11856339
申请日:2007-09-17
申请人: Seiji Ohno , Kayo Otani , Seiji Niwa , Satoshi Iwayama , Akira Takahara , Hajime Koganei , Yukitsugu Ono , Shinichi Fujita , Tomoko Takeda , Masako Hagihara , Akiko Okajima
发明人: Seiji Ohno , Kayo Otani , Seiji Niwa , Satoshi Iwayama , Akira Takahara , Hajime Koganei , Yukitsugu Ono , Shinichi Fujita , Tomoko Takeda , Masako Hagihara , Akiko Okajima
IPC分类号: C07D213/82 , C07D213/80 , C07D401/06 , A61K31/455 , A61K31/496
CPC分类号: C07D213/80 , A61K31/455 , A61K31/496 , A61K31/505 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K31/551 , C07D213/82 , C07D239/28 , C07D239/34 , C07D239/38 , C07D239/42 , C07D401/04 , C07D403/04 , C07D409/04 , C07D417/04
摘要: Achiral pyrimidine derivatives and pyridine derivatives of the following formulae or analogs thereof have selective N-type calcium channel antagonistic activity and showed analgesic action when they were taken orally. They are useful as therapeutic agents for pains and various diseases associated with the N-type calcium channels.
摘要翻译: 下列通式或其类似物的手性嘧啶衍生物和吡啶衍生物具有选择性的N型钙通道拮抗活性,口服时显示镇痛作用。 它们可用作与N型钙通道相关的疼痛和各种疾病的治疗剂。
-
公开(公告)号:US06610717B2
公开(公告)日:2003-08-26
申请号:US10023813
申请日:2001-12-21
申请人: Akira Nakajo , Munetaka Tokumasu , Morikazu Kito , Akira Takahara , Yukitsugu Ono , Tomoko Takeda , Yuki Kajigaya , Hajime Koganei
发明人: Akira Nakajo , Munetaka Tokumasu , Morikazu Kito , Akira Takahara , Yukitsugu Ono , Tomoko Takeda , Yuki Kajigaya , Hajime Koganei
IPC分类号: A61K3144
CPC分类号: C07D401/12 , C07D211/90
摘要: Dihydropyridine derivatives represented by the following formula: analogs thereof and pharmaceutically acceptable salts thereof have an activity of selectively inhibiting the action of N-type calcium channel, and they are used as therapeutic agents for various diseases relating to N-type calcium channel.
摘要翻译: 由下式表示的二氢吡啶衍生物:其类似物和其药学上可接受的盐具有选择性抑制N型钙通道作用的活性,并且它们用作各种与N-型钙通道有关的疾病的治疗剂。
-
公开(公告)号:US07462630B2
公开(公告)日:2008-12-09
申请号:US10787175
申请日:2004-02-27
申请人: Takashi Yamamoto , Seiji Niwa , Kayo Otani , Seiji Ohno , Hajime Koganei , Satoshi Iwayama , Akira Takahara , Yukitsugu Ono , Tomoko Takeda , Shinichi Fujita , Keiko Moki
发明人: Takashi Yamamoto , Seiji Niwa , Kayo Otani , Seiji Ohno , Hajime Koganei , Satoshi Iwayama , Akira Takahara , Yukitsugu Ono , Tomoko Takeda , Shinichi Fujita , Keiko Moki
IPC分类号: A61K31/445 , C07D409/14
CPC分类号: C07D295/205 , C07C237/06 , C07C271/20 , C07C271/22 , C07D211/70 , C07D401/04 , C07D401/12 , C07D405/12 , C07D409/04 , C07D417/06
摘要: The invention relates to a compound represented by the following general formula (1) or its analogue, which selectively inhibit N-type calcium channels or its analogue, and to a method for treating pain etc. comprising the compound represented by the following general formula (1) or its analogue to a patient in need of such treatment: wherein, A represents CH═CH, etc., a, b, c and d represents CH etc., R1, R2, R3, R4, R5 and R6 represents H etc., V—W represents C═C, etc., n represents 0 to 3, Y1 represents O etc., B represents —(CH2)vCHR21 wherein v is 0 to 3, R21 represents H, a lower alkyl group or the like, etc., G represents —CO—, a covalent bond, etc., m is 0 to 6, R7 and R8 represents H, a lower alkyl group, —COR18a, —COOR20 wherein R18a and R20 each represents a lower alkyl group or the like, etc.
摘要翻译: 本发明涉及由以下通式(1)表示的化合物或其类似物,其选择性地抑制N-型钙通道或其类似物,以及涉及治疗疼痛等的方法,其包含由以下通式表示的化合物 1)或其与需要这种治疗的患者的类似物:其中A表示CH-CH等,a,b,c和d表示CH等,R 1,R 2,R 3,R 4,R 5和R 6表示H 等等,VW表示CC等,n表示0〜3,Y1表示O等,B表示 - (CH2)vCHR21,其中v为0-3,R21表示H,低级烷基等。 ,G表示-CO-,共价键等,m为0〜6,R7和R8表示H,低级烷基,-COR18a,-COOR20,其中R18a和R20各自表示低级烷基等, 等等
-
8.
公开(公告)号:US20080058311A1
公开(公告)日:2008-03-06
申请号:US11924997
申请日:2007-10-26
申请人: Takashi YAMAMOTO , Seiji Niwa , Kayo Otani , Seiji Ohno , Hajime Koganei , Satoshi Iwayama , Akira Takahara , Yukitsugu Ono , Tomoko Takeda , Shinichi Fujita , Keiko Moki
发明人: Takashi YAMAMOTO , Seiji Niwa , Kayo Otani , Seiji Ohno , Hajime Koganei , Satoshi Iwayama , Akira Takahara , Yukitsugu Ono , Tomoko Takeda , Shinichi Fujita , Keiko Moki
IPC分类号: A61K31/55 , A61K31/215 , A61K31/40 , A61K31/445 , A61P25/00 , C07C69/00 , C07D221/00 , C07D295/00 , C07D223/02 , C07D207/00 , A61P43/00 , A61P11/06 , A61K31/4523 , A61K31/495
CPC分类号: C07D295/205 , C07C237/06 , C07C271/20 , C07C271/22 , C07D211/70 , C07D401/04 , C07D401/12 , C07D405/12 , C07D409/04 , C07D417/06
摘要: The invention relates to a compound represented by the following general formula (1) or its analogue, which selectively inhibit N-type calcium channels or its analogue, and to a method for treating pain etc. comprising the compound represented by the following general formula (1) or its analogue to a patient in need of such treatment: wherein, A represents CH═CH, etc., a, b, c and d represents CH etc., R1, R2, R3, R4, R5 and R6 represents H etc., V—W represents C═C, etc., n represents 0 to 3, Y1 represents O etc., B represents —(CH2)vCHR21 wherein v is 0 to 3, R21 represents H, a lower alkyl group or the like, etc., G represents —CO—, a covalent bond, etc., m is 0 to 6, R7 and R8 represents H, a lower alkyl group, —COR18a, —COOR20 wherein R18a and R20 each represents a lower alkyl group or the like, etc.
摘要翻译: 本发明涉及由以下通式(1)表示的化合物或其类似物,其选择性地抑制N-型钙通道或其类似物,以及涉及治疗疼痛等的方法,其包含由以下通式表示的化合物 1)或其与需要这种治疗的患者的类似物:其中A表示CH-CH等,a,b,c和d表示CH等,R 1,R 2,R 3,R 4,R 5和R 6表示H 等等,VW表示CC等,n表示0〜3,Y1表示O等,B表示 - (CH2)vCHR21,其中v为0-3,R21表示H,低级烷基等。 ,G表示-CO-,共价键等,m为0〜6,R7和R8表示H,低级烷基,-COR18a,-COOR20,其中R18a和R20各自表示低级烷基等, 等等
-
公开(公告)号:US08278329B2
公开(公告)日:2012-10-02
申请号:US11924997
申请日:2007-10-26
申请人: Takashi Yamamoto , Seiji Niwa , Kayo Otani , Seiji Ohno , Hajime Koganei , Satoshi Iwayama , Akira Takahara , Yukitsugu Ono , Tomoko Takeda , Shinichi Fujita , Keiko Moki
发明人: Takashi Yamamoto , Seiji Niwa , Kayo Otani , Seiji Ohno , Hajime Koganei , Satoshi Iwayama , Akira Takahara , Yukitsugu Ono , Tomoko Takeda , Shinichi Fujita , Keiko Moki
IPC分类号: A61K31/445 , C07D211/18
CPC分类号: C07D295/205 , C07C237/06 , C07C271/20 , C07C271/22 , C07D211/70 , C07D401/04 , C07D401/12 , C07D405/12 , C07D409/04 , C07D417/06
摘要: The invention relates to a compound represented by the following general formula (1) or its analogue, which selectively inhibit N-type calcium channels or its analogue, and to a method for treating pain etc. comprising the compound represented by the following general formula (1) or its analogue to a patient in need of such treatment: wherein, A represents CH═CH, etc., a, b, c and d represents CH etc., R1, R2, R3, R4, R5 and R6 represents H etc., V—W represents C═C, etc., n represents 0 to 3, Y1 represents O etc., B represents —(CH2)vCHR21 wherein v is 0 to 3, R21 represents H, a lower alkyl group or the like, etc., G represents —CO—, a covalent bond, etc., m is 0 to 6, R7 and R8 represents H, a lower alkyl group, —COR18a, —COOR20 wherein R18a and R20 each represents a lower alkyl group or the like, etc.
摘要翻译: 本发明涉及由以下通式(1)表示的化合物或其类似物,其选择性地抑制N-型钙通道或其类似物,以及涉及治疗疼痛等的方法,其包含由以下通式表示的化合物 1)或其与需要这种治疗的患者的类似物:其中A表示CH = CH等,a,b,c和d表示CH等,R 1,R 2,R 3,R 4,R 5和R 6表示H 等等,V-W表示C = C等,n表示0〜3,Y 1表示O等,B表示 - (CH 2)v CHR 21,其中v为0〜3,R 21表示H,低级烷基或 G等表示-CO-,共价键等,m为0〜6,R7和R8表示H,低级烷基,-COR18a,-COOR20,其中R18a和R20各自表示低级烷基 或类似物等
-
公开(公告)号:US06350762B1
公开(公告)日:2002-02-26
申请号:US09403575
申请日:1999-10-25
申请人: Seiji Niwa , Seiji Ohno , Tomoyuki Onishi , Morikazu Kito , Akira Takahara , Yukitsugu Ono , Hisayuki Uneyama
发明人: Seiji Niwa , Seiji Ohno , Tomoyuki Onishi , Morikazu Kito , Akira Takahara , Yukitsugu Ono , Hisayuki Uneyama
IPC分类号: A61K31444
CPC分类号: C07D231/12 , C07D211/90 , C07D233/56 , C07D249/08 , C07D401/12 , C07D405/04 , C07D491/04
摘要: Dihydropyridine derivatives of the following formula, analogs thereof and pharmaceutically acceptable salts thereof have an activity of selectively inhibiting the action of N-type calcium channel. They are used as remedies for various diseases relating to the N-type calcium channel.
摘要翻译: 下式的二氢吡啶衍生物,其类似物和其药学上可接受的盐具有选择性抑制N型钙通道作用的活性。 它们被用作与N型钙通道有关的各种疾病的补救措施。
-
-
-
-
-
-
-
-
-